Today, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Incyte Corp. v. Sun Pharmaceutical Industries, Ltd. dismissing Incyte’s appeal from post-grant review (PGR) proceedings at the Patent Trial and Appeal Board (PTAB) for lack of Article III standing. While the Federal Circuit majority deciding the case found that Incyte couldn’t establish a sufficient injury in fact, Circuit Judge Todd Hughes authored a concurrence echoing his previous concerns regarding the appellate court’s overly rigid and narrow standard for analyzing standing in PTAB appeals.
Recent Posts
- Senate IP Subcommittee Talks Legislative Fixes for China’s Threats to American Innovation Leadership
- Another Director Review Request Demonstrates Extent of PTAB Hubris
- The Existential Threat of AI Consciousness | IPWatchdog Unleashed
- Latest Trump Executive Order Redirects Drug Pricing Debate
- Lutnick Tells Inventors, ‘You Have a Friend’ at Commerce